ICD-10 Code B78.9 | Strongyloidiasis, unspecified Symptoms, Diagnosis, Billing

Strongyloidiasis, unspecified, is a parasitic infection caused by the Strongyloides stercoralis worm. This condition can lead to significant morbidity, particularly in immunocompromised individuals. Accurate coding with ICD-10 Code B78.9 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this infection.

What is ICD-10 Code B78.9 for Strongyloidiasis, unspecified?

ICD-10 Code B78.9 represents Strongyloidiasis, unspecified, which refers to an infection caused by the Strongyloides stercoralis parasite without specifying the severity or manifestations. This code should be used when documenting cases of strongyloidiasis that do not have further classification, ensuring accurate billing and clinical documentation.

ICD-10 Code B78.9 – Clinical Definition and Explanation of Strongyloidiasis, unspecified

Strongyloidiasis is caused by the Strongyloides stercoralis parasite, which can lead to chronic infection and severe complications, especially in immunocompromised patients. Early diagnosis and treatment are crucial to prevent serious health issues.

Key Clinical Features:

• Asymptomatic in many cases, but can cause gastrointestinal symptoms.
• Potential for severe complications, including hyperinfection syndrome.
• Common in tropical and subtropical regions, affecting those with exposure to contaminated soil.
• Diagnosis often requires serological testing or stool examination.

ICD-10 Code B78.9 for Strongyloidiasis, unspecified – SOAP Notes & Clinical Use

ICD-10 Code B78.9 is utilized in SOAP notes to document the presence of strongyloidiasis, guiding the assessment and treatment plan. It is relevant in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code B78.9 for Strongyloidiasis, unspecified Mean in SOAP Notes?

In SOAP notes, ICD-10 Code B78.9 connects subjective patient reports and objective clinical findings to a formal diagnosis of strongyloidiasis. This code supports continuity of care, facilitates billing, and meets EHR documentation standards.

Treatment Options for ICD-10 Code B78.9 – Strongyloidiasis, unspecified

Strongyloidiasis requires prompt medical attention, particularly in immunocompromised individuals. Treatment typically involves antiparasitic medications.

Antibiotic Therapy:

• Ivermectin: First-line treatment, typically administered as a single dose or repeated doses for severe cases.
• Albendazole: Alternative treatment option, often used in combination with ivermectin.
• Duration of treatment may vary based on clinical response.

Supportive Care:

• Manage symptoms such as abdominal pain and diarrhea.
• Monitor for signs of hyperinfection or disseminated strongyloidiasis.
• Provide hydration and nutritional support as needed.

Infection Control:

• Educate patients on hygiene practices to prevent reinfection.
• Implement precautions in healthcare settings to prevent transmission.
• Consider screening for strongyloidiasis in at-risk populations.

How to Document Symptoms of Strongyloidiasis, unspecified (ICD-10 B78.9) in SOAP Notes

Subjective:

• Patient reports abdominal pain and intermittent diarrhea.
• History of travel to endemic areas with exposure to contaminated soil.
• Complaints of fatigue and weight loss over the past few months.

Objective:

• Vital signs: Stable, no fever.
• Abdominal examination reveals tenderness in the epigastric region.
• Stool test shows presence of Strongyloides larvae.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Strongyloidiasis, unspecified (ICD-10 Code B78.9)

Assessment:

• Diagnosis: Strongyloidiasis, unspecified (ICD-10 B78.9).
• Severity: Moderate, given gastrointestinal symptoms.
• Contributing factors: Recent travel to endemic region.

Plan:

• Initiate treatment with ivermectin as per guidelines.
• Educate patient on hygiene and prevention strategies.
• Schedule follow-up in two weeks to assess treatment response.

Treatment & Plan Section for ICD-10 Code B78.9 – Strongyloidiasis, unspecified

• First-line treatment with ivermectin, monitor for side effects.
• Consider nutritional support for weight loss and fatigue.
• Follow-up stool examination to confirm treatment efficacy.
• Educate on prevention of reinfection and hygiene practices.

Using ICD-10 Code B78.9 for Strongyloidiasis, unspecified in Billing & SOAP Note Compliance

• Ensure clear documentation of symptoms and clinical findings in SOAP notes.
• Use B78.9 for cases without further specification to support billing.
• Align treatment plans with clinical guidelines for justified billing.
• Document any related complications or comorbidities for accurate coding.

Related ICD-10 Codes Often Used with Strongyloidiasis, unspecified

• B78.0 – Strongyloidiasis due to Strongyloides stercoralis
• B78.1 – Strongyloidiasis due to Strongyloides stercoralis, hyperinfection
• B74.9 – Other protozoal diseases, unspecified

ICD-10 Code B78.9 in Medical Billing and Insurance for Strongyloidiasis, unspecified

ICD-10 Code B78.9 is critical for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings to support the use of B78.9.
• Use this code in conjunction with detailed treatment plans for billing.
• Ensure compliance with payer requirements for documentation.

Common CPT Pairings: